Standard BioTools Relocates HQ, Hints at Officer Changes

Ticker: LAB · Form: 8-K · Filed: Jan 10, 2025 · CIK: 1162194

Standard Biotools Inc. 8-K Filing Summary
FieldDetail
CompanyStandard Biotools Inc. (LAB)
Form Type8-K
Filed DateJan 10, 2025
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001, $441,000, $169,785, $21,264
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, executive-changes, filing-update

TL;DR

Standard BioTools moved its HQ and might be shuffling execs/board. Keep an eye out.

AI Summary

Standard BioTools Inc. announced on January 3, 2025, a change in its principal executive offices to 2 Tower Place, Suite 2000, South San Francisco, California 94080. This filing also indicates potential changes related to directors, officers, and compensatory arrangements, though specific details are not provided in this excerpt.

Why It Matters

A change in principal executive offices can signal strategic shifts or operational adjustments for the company. Potential changes in officer compensation or board composition may impact corporate governance and future strategy.

Risk Assessment

Risk Level: low — The filing primarily reports a change of address and general information about potential officer and director changes, without detailing any negative events or significant financial impacts.

Key Players & Entities

  • Standard BioTools Inc. (company) — Registrant
  • 2 Tower Place, Suite 2000, South San Francisco, California 94080 (location) — New Principal Executive Offices
  • January 3, 2025 (date) — Date of earliest event reported

FAQ

What is the new address for Standard BioTools Inc.'s principal executive offices?

The new address is 2 Tower Place, Suite 2000, South San Francisco, California 94080.

What is the date of the earliest event reported in this 8-K filing?

The date of the earliest event reported is January 3, 2025.

What is the Commission File Number for Standard BioTools Inc.?

The Commission File Number is 001-34180.

What is the IRS Employer Identification Number for Standard BioTools Inc.?

The IRS Employer Identification Number is 77-0513190.

What are the general topics covered by this 8-K filing?

This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.

Filing Stats: 722 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2025-01-10 16:09:41

Key Financial Figures

  • $0.001 — nge on which registered Common stock, $0.001 par value per share LAB Nasdaq Glob
  • $441,000 — a twelve-month period, which will total $441,000, (ii) Mr. Davis will be entitled to rec
  • $169,785 — r the 2024 fiscal year in the amount of $169,785, (iii) the Company will pay Mr. Davis a
  • $21,264 — is current annual target bonus equal to $21,264.65, (iv) the Company will pay the costs

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 10, 2025 STANDARD BIOTOOLS INC. By: /s/ Alex Kim Name: Alex Kim Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.